Market Tracker

10/30 10:23am ET
14.95
Real-Time Quote
 +3.37 / +29.10%
Today’s Change
6.92
Today|||52-Week Range
18.80
+32.42%
Year-to-Date

Today’s Trading

Previous close11.58
Today’s open11.85
Day’s range11.85 - 13.90
Volume189,619
Average volume (3 months)303,776
Market cap$393.7M
Dividend yield--
Data as of 10:08am ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+12.58%
Earnings growth (this year)-59.57%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)-73.43%
P/E ratioNM
Price/Sales201.53
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.07+0.58%
TKMRTekmira Pharmaceutic...+0.08+0.47%
DERMDermira Inc-0.22-1.33%
SCLNSciClone Pharmaceuti...+0.02+0.25%
Data as of 10:23am ET, 10/30/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$1.6M
Annual profit (last year)-$39.8M
Net profit margin-2,487.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts